Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Reimus Valencia"'
Autor:
Marija Rowane OMS-II, Reimus Valencia DO, Jason Schend DO, Devi Jhaveri DO, FACOP, FAAP, Robert Hostoffer DO, LhD, MSMEd, FAAP, FACOP, FACOI, FCCP
Publikováno v:
Allergy & Rhinology, Vol 11 (2020)
Introduction Atopic dermatitis (AD, eczema) is familial chronic inflammatory skin disease of complex etiology and increasing prevalence. Dupilumab is an IL-4 receptor subunit alpha (IL-4Rα) antagonist that is the first Food and Drug Administration-a
Externí odkaz:
https://doaj.org/article/b8bf0d2552e24e799cf1f90380f976d5
Autor:
Marija Rowane OMS-II, Reimus Valencia DO, Benjamin Stewart-Bates OMS-IV, Jason Casselman DO, Robert Hostoffer DO, LhD, MSMEd, FAAP, FACOP, FACOI, FCCP
Publikováno v:
Allergy & Rhinology, Vol 10 (2019)
Introduction Alpha (⍺)-gal syndrome (AGS) is an immunoglobulin E (IgE) antibody response against the glycoprotein carbohydrate galactose-⍺-1,3-galactose-β-1-(3)4-N-acetylglucosamine-R (Gal⍺-1,3Galβ1-(3)4GlcNAc-R or ⍺-gal) that is present in
Externí odkaz:
https://doaj.org/article/9d8faeb801e841b5a5da34723f7a812f
Publikováno v:
Scholar: Pilot and Validation Studies. 3:6-9
Introduction In a suburban allergy outpatient office, the practice of epinephrine rinse of subcutaneous allergen immunotherapy (SCIT) syringes prior to injection has been employed for over 30 years with documented favorable clinical outcomes. A retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e301c6c521095d6122dee8b6e3fa41e5
https://doi.org/10.32778/spvs.71366.2022.29
https://doi.org/10.32778/spvs.71366.2022.29
Publikováno v:
Allergy & Rhinology, Vol 11 (2020)
Allergy & Rhinology
Allergy & Rhinology
Introduction Atopic dermatitis (AD, eczema) is familial chronic inflammatory skin disease of complex etiology and increasing prevalence. Dupilumab is an IL-4 receptor subunit alpha (IL-4Rα) antagonist that is the first Food and Drug Administration-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d8668cc6e1c2a567de08879244863eb
https://doaj.org/article/b8bf0d2552e24e799cf1f90380f976d5
https://doaj.org/article/b8bf0d2552e24e799cf1f90380f976d5
Publikováno v:
Allergy & Rhinology
Allergy & Rhinology, Vol 10 (2019)
Allergy & Rhinology, Vol 10 (2019)
Introduction Alpha (⍺)-gal syndrome (AGS) is an immunoglobulin E (IgE) antibody response against the glycoprotein carbohydrate galactose-⍺-1,3-galactose-β-1-(3)4-N-acetylglucosamine-R (Gal⍺-1,3Galβ1-(3)4GlcNAc-R or ⍺-gal) that is present in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbd041fdbd90fdf0924e10e5fa254e6a
http://europepmc.org/articles/PMC6902388
http://europepmc.org/articles/PMC6902388
Publikováno v:
Journal of Allergy and Clinical Immunology. 147:AB130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbbebc59d9b43ea4ea71754847015977
https://doi.org/10.1016/j.jaci.2020.12.476
https://doi.org/10.1016/j.jaci.2020.12.476
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 7:754
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3649fe824e656ab4a8051a278a0ff677
https://doi.org/10.1016/j.jaip.2018.10.056
https://doi.org/10.1016/j.jaip.2018.10.056